New 'Vaccine' strategy tested for Tough-to-Treat pancreatic cancer
NCT ID NCT05721846
Summary
This early-stage study is testing a four-part combination treatment for advanced pancreatic cancer that has stopped responding to standard chemotherapy. The treatment includes two immunotherapy drugs, a targeted vaccine, and a single dose of precise radiation. The main goal is to see if this new approach is safe and tolerable for up to 20 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Herlev & Gentofte University Hospital, Denmark
Herlev, 2730, Denmark
Conditions
Explore the condition pages connected to this study.